0000000000378887

AUTHOR

Itahisa Marcelino-rodríguez

0000-0003-3645-3207

showing 2 related works from this author

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care

2017

Aims: To evaluate the applicability and cost-effectiveness of a clinical risk score (DIABSCORE) to screen for type 2 diabetes in primary care patients. Methods: Multicenter cross-sectional study of 10,508 adult no previously diagnosed with diabetes, in 2 Spanish regions (Canary Islands and Valencian Community). The variables comprising DIABSCORE were age, waist to height ratio, family history of diabetes and gestational diabetes. ROC curves were obtained; the diabetes prevalences odds ratios (HbA1c >= 6.5%) between patients exposed and not exposed to DIABSCORE >= 100, and to fasting blood glucose >= 126 mg/dL were calculated. The opinions of both the professionals and the patients concernin…

AdultBlood Glucosemedicine.medical_specialtyCost effectivenessEndocrinology Diabetes and MetabolismCost-Benefit AnalysisType 2 diabetes030204 cardiovascular system & hematologyValencianCost effectiveness03 medical and health sciences0302 clinical medicineEndocrinologyPregnancyInternal medicineDiabetes mellitusInternal MedicinemedicineOdds RatioPrevalenceHumansMass Screening030212 general & internal medicineFamily historyPrimary health careWaist-to-height ratioClinic epidemiologyPrimary Health Carebusiness.industryType 2 diabetesGeneral MedicineOdds ratioMiddle Agedmedicine.diseaselanguage.human_languageGestational diabetesCross-Sectional StudiesDiabetes Mellitus Type 2ROC CurveSpainEmergency medicinelanguageScreeningFemalebusiness
researchProduct

Whole-Blood Mitochondrial DNA Copies Are Associated With the Prognosis of Acute Respiratory Distress Syndrome After Sepsis

2021

Acute respiratory distress syndrome (ARDS) is an inflammatory process of the lungs that develops primarily in response to pulmonary or systemic sepsis, resulting in a disproportionate death toll in intensive care units (ICUs). Given its role as a critical activator of the inflammatory and innate immune responses, previous studies have reported that an increase of circulating cell-free mitochondrial DNA (mtDNA) is a biomarker for fatal outcome in the ICU. Here we analyzed the association of whole-blood mtDNA (wb-mtDNA) copies with 28-day survival from sepsis and sepsis-associated ARDS. We analyzed mtDNA data from 687 peripheral whole-blood samples within 24 h of sepsis diagnosis from unrelat…

MaleMitochondrial DNAARDSTime FactorsMedicinaImmunologyDNA MitochondrialRisk AssessmentsurvivalSepsisPathogenesisPredictive Value of TestsRisk FactorsIntensive careSepsismedicineImmunology and AllergyHumansHospital MortalityOriginal ResearchAgedRespiratory Distress SyndromeDAMPsProportional hazards modelbusiness.industrymtDNAHazard ratiowhole bloodMiddle AgedRC581-607medicine.diseasePrognosismitochondriaSpainImmunologyBiomarker (medicine)FemaleARDSImmunologic diseases. AllergybusinessBiomarkersFrontiers in Immunology
researchProduct